HCPCS Codes Similar to G8944

HCPCS Codes Similar to “G8944” Code.
Ajcc melanoma cancer stage 0 through iic melanoma

M1386 Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	G8927 Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer Code added date: 20130101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9704 Ajcc breast cancer stage i: t1 mic or t1a documented Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9705 Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9831 Ajcc stage at breast cancer diagnosis = ii or iii Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9832 Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G0219 Pet imaging whole body; melanoma for non-covered indications Code added date: 20010701 Code effective date: 20010701 TXT \| PDF \| XML \| JSON	G8749 Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma) Code added date: 20120101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G8750 Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or presence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma) Code added date: 20120101 Code effective date: 20130101 TXT \| PDF \| XML \| JSON	G9292 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons) Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON
G9785 Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist Code added date: 20170101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON	G9786 Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist Code added date: 20170101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON
M1388 Patients with documentation of an exam performed for recurrence of melanoma Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1390 Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON